Liraglutide · 2026-08-06
ClinicalTrials.gov record NCT05313529
Completed at the retained observation.
Open attributed record →Official registry phase
Not applicable peptide trials
12 selected ClinicalTrials.gov records carrying the official Not applicable designation. Phase is reported exactly as supplied by the retained registry version; records without a supplied phase are not inferred into this page.
Registry records
12 selected records.
Connected peptides
6 profiles.
Source boundary
ClinicalTrials.gov phase field.
Attributed registry records
Selected records
Linaclotide · 2026-07-29
ClinicalTrials.gov record NCT05796388
Recruiting at the retained observation.
Open attributed record →Semaglutide · 2026-07-28
ClinicalTrials.gov record NCT07732426
Recruiting at the retained observation.
Open attributed record →Glucagon · 2026-04-20
ClinicalTrials.gov record NCT06424106
Recruiting at the retained observation.
Open attributed record →Semaglutide · 2025-01-08
ClinicalTrials.gov record NCT06764056
Not yet recruiting at the retained observation.
Open attributed record →Pramlintide · 2023-10-25
ClinicalTrials.gov record NCT05199714
Completed at the retained observation.
Open attributed record →Leuprolide · 2017-11-20
ClinicalTrials.gov record NCT01762943
Completed at the retained observation.
Open attributed record →Leuprolide · 2015-03-26
ClinicalTrials.gov record NCT00004426
Completed at the retained observation.
Open attributed record →Leuprolide · 2015-03-25
ClinicalTrials.gov record NCT00004436
Completed at the retained observation.
Open attributed record →Leuprolide · 2015-03-25
ClinicalTrials.gov record NCT00004438
Completed at the retained observation.
Open attributed record →Leuprolide · 2014-06-04
ClinicalTrials.gov record NCT01669291
Completed at the retained observation.
Open attributed record →Liraglutide · 2013-04-19
ClinicalTrials.gov record NCT01469351
Completed at the retained observation.
Open attributed record →